Cross-Border Cancer Screening in Europe: Why Equal Access Matters, Dr. Savvas Petanidis
Dr. Savvas Petanidis, Principal Investigator of the Tumor Immunology Group at Papanikolaou Hospital and Aristotle University of Thessaloniki (AUTH), gives us details about why cross-border healthcare is essential for early detection of breast, prostate, and lung cancers. He explains how European citizens can access screening in another Member State under Directive 2011/24/EU, ensuring that geography doesn’t limit someone’s chance of early diagnosis.
He also highlights how digital health networks like MyHealth@EU allow screening images and reports to be shared securely across borders, and how AI and European quality standards help support radiologists and guarantee safe, consistent care.
With the EU Cancer Plan expanding organised screening to include lung and prostate cancers, Europe is moving toward more equal access for all — no matter where people live.